Reshaping the HIV treatment and prevention landscape
Transformed commercial capabilities and organisation
Re-shaping the organization
Leadership and capabilities
-
-
-
>90% sales revenue under new leadership
Re-built commercial interface with R&D
>900 new hires in Specialty Care
Reshaped organisation to focus on growth
-
-
-
Focused footprint from ~140 to ~70 countries
Concentrated investment in top 10 markets
De-layered and simplified organisation
Reduced back office
-
-
Significant reduction in non-customer facing commercial infrastructure
Re-allocated savings to growth markets/brands
Optimised policies
-
-
Aligned Healthcare Professional engagement policies to best practice
Improved competitiveness, maintained trust
New General Managers appointed
in 64 of 70 countries
New General manager appointed
No change
No local operations
gsk
29View entire presentation